Literature DB >> 2853967

Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase.

N K Tonks1, H Charbonneau, C D Diltz, E H Fischer, K A Walsh.   

Abstract

It has been proposed on the basis of amino acid sequence homology that the leukocyte common antigen CD45 represents a family of catalytically active, receptor-linked protein tyrosine phosphatases [Charbonneau, H., Tonks, N. K., Walsh, K. A., & Fischer, E. H. (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 7182-7186]. The present study confirms that CD45 possesses intrinsic protein tyrosine phosphatase (PTPase) activity. First, a mouse monoclonal antibody to CD45 (mAb 9.4) specifically eliminated, by precipitation, PTPase activity from a high Mr fraction containing CD45, prepared by gel filtration (Sephacryl S200) of a Triton X-100 extract of human spleen. Second, PTPase activity was demonstrated in a highly purified preparation of CD45 that was eluted with a high pH buffer from an affinity column, constructed from the same antibody. Third, on sucrose density gradient centrifugation, PTPase activity was only found in those fractions that contained CD45 as determined by Western analysis. When CD45 was caused to aggregate, first by reacting it with mAb 9.4 and then adding a secondary, cross-linking anti-mouse mAb, the PTPase activity shifted to the same higher Mr fractions that contained CD45. No shift in CD45 or PTPase was observed following addition of a control IgG2a. On this basis, it is concluded that CD45 is a protein tyrosine phosphatase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2853967     DOI: 10.1021/bi00424a001

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  94 in total

1.  A family of receptor-linked protein tyrosine phosphatases in humans and Drosophila.

Authors:  M Streuli; N X Krueger; A Y Tsai; H Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Molecular cloning, nucleotide sequence and expression of a cDNA encoding an intracellular protein tyrosine phosphatase, PTPase-2, from mouse testis and T-cells.

Authors:  H Miyasaka; S S Li
Journal:  Mol Cell Biochem       Date:  1992-12-02       Impact factor: 3.396

3.  Expression of soluble isoforms of rat CD45. Analysis by electron microscopy and use in epitope mapping of anti-CD45R monoclonal antibodies.

Authors:  M N McCall; D M Shotton; A N Barclay
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

4.  CD22-mediated stimulation of T cells regulates T-cell receptor/CD3-induced signaling.

Authors:  A Aruffo; S B Kanner; D Sgroi; J A Ledbetter; I Stamenkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 5.  Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation.

Authors:  L T Clement
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

Review 6.  Structure and function of the T cell antigen receptor.

Authors:  A Weiss
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

7.  Interleukin 2 regulates Raf-1 kinase activity through a tyrosine phosphorylation-dependent mechanism in a T-cell line.

Authors:  B C Turner; N K Tonks; U R Rapp; J C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

8.  Substrate specificity of the protein tyrosine phosphatases.

Authors:  Z Y Zhang; A M Thieme-Sefler; D Maclean; D J McNamara; E M Dobrusin; T K Sawyer; J E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

9.  Protein kinase C isoform expression in CD45RA+ and CD45RO+ T lymphocytes.

Authors:  E Corrigan; D Kelleher; C Feighery; A Long
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

10.  Beta 1 integrins mediate adherent phenotype of human erythroblastic cell lines after phorbol 12-myristate 13-acetate induction.

Authors:  A Molla; R Berthier; A Chapel; A Schweitzer; A Andrieux
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.